A case of stent thrombosis occurred at 5 years after sirolimus-eluting stent implantation.

about

A case of stent thrombosis occurred at 5 years after sirolimus-eluting stent implantation.

Item

http://www.wikidata.org/entity/Q39066560

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

A case of stent thrombosis occ ...... us-eluting stent implantation.

@en

A case of stent thrombosis occ ...... us-eluting stent implantation.

@nl

type

Item

label

A case of stent thrombosis occ ...... us-eluting stent implantation.

@en

A case of stent thrombosis occ ...... us-eluting stent implantation.

@nl

prefLabel

A case of stent thrombosis occ ...... us-eluting stent implantation.

@en

A case of stent thrombosis occ ...... us-eluting stent implantation.

@nl

P1476

A case of stent thrombosis occ ...... us-eluting stent implantation.

@en

P2093

Sang Yup Lim

http://www.w3.org/2001/XMLSchema#string

Su A Kim

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

Long-term care after percutaneous coronary intervention: focus on the role of antiplatelet therapy

Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent data from an observational cohort study of drug-eluting versus bare-metal stents.

Very late stent thrombosis 42 months after implantation of sirolimus-eluting stent and discontinuation of antiplatelet therapy.

Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).

Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy

Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

Prevalence, Predictors, and Long-Term Prognosis of Premature Discontinuation of Oral Antiplatelet Therapy After Drug Eluting Stent Implantation

P304

124-126

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.4068/CMJ.2011.47.2.124

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51824612

http://www.w3.org/2001/XMLSchema#string

P698

22111073

http://www.w3.org/2001/XMLSchema#string

P932

3214865

http://www.w3.org/2001/XMLSchema#string